Synopsis of recent research by authors named "Fuat S Oduncu"
- Fuat S Oduncu's recent research primarily focuses on the development of innovative therapeutic strategies for cancer, particularly targeting human epidermal growth factor receptor 2 (HER2)-positive esophagogastric adenocarcinoma and acute myeloid leukemia (AML) through immunotherapy and chemotherapy combinations.
- His studies demonstrate significant advancements in perioperative chemotherapy regimens, such as the FLOT regimen, highlighting its efficacy and safety compared to traditional treatments for advanced gastric and esophagogastric cancers, and indicating improved survival outcomes.
- Additionally, Oduncu's work encompasses the identification of novel biomarkers, such as microRNA-192-5p and the association of mismatch repair status with clinical survival in colorectal cancer, aiming to enhance predictive diagnostics and tailor patient treatment plans.